Elizabeth Holmes: The Rise and Fall of a $9 Billion Scam

A machine that never worked. A $9 billion valuation. Henry Kissinger, Rupert Murdoch and Walgreens on board. And not one of them asked to see it run. Theranos fraud cases remain a masterclass in corporate manipulation. We examine how Elizabeth Holmes secured billions in capital. This breakdown tracks the rise and fall of a company that promised to change healthcare but delivered zero functional tests. We look at the high-stakes environment that allowed a massive valuation to persist despite internal warnings and a lack of proven technology. By analyzing the role of influential board members and the pressure to maintain hype, we can see how the Theranos story bypassed standard due diligence. This review highlights the critical gaps in oversight that kept the deception alive long enough to attract the wealthiest families in America. Subscribe for weekly business history breakdowns, and let me know in the comments if you think the Theranos board or the investors were more responsible for the failure. 0:00 The $9 Billion Mirage 1:54 The Promise of a Single Drop 4:08 The Chain With No Anchor 7:50 The Null Protocol Revealed 10:42 The House of Cards Collapses